Clinical Trial Update: A Real-World Study of Omalizumab Treatment Patterns in Chronic Urticaria Patients in China

View source ↗

Summary

This real-world study evaluates omalizumab treatment patterns in Chinese patients with chronic urticaria. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urticaria

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Urticaria | Status: COMPLETED